Transitioning your therapeutic peptide programme from research to clinic
Alastair Hay walks through some of the key considerations facing the transition of peptide therapeutic programmes to clinic.
The field of peptide therapeutics is alive and well, and the landscape has changed to incorporate creative solutions to some of the disadvantages they present as a class of molecule. Giving
consideration to a few concepts can help smooth transition from research to the clinical arena.
Download the article to find out more.
View Resource